https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-cls-staging.hbrsd.com/media/rtlo1nwq/may-cover.jpg
Contact Lens Spectrum
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-cls-staging.hbrsd.com/media/zf0kqy3n/cover1.jpg
Eyecare Business
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-cls-staging.hbrsd.com/media/11skpyd5/om-mayjune-2026-cover.jpg
Optometric Management
VideoMastering Myopia Interviews
Jeff Schilling is a resident of Boulder, Colorado, with a fascinating eye history. As a child in Olmsted County, Minnesota, he was part of a very early study of 1% atropine. He ended up using atropine for around 10 years. As an adult, he had bilateral radial keratotomy. Finally, he developed cataracts at a relatively young age—something he attributes to a number of factors.
